University Clinical Hospital Virgen De La Arrixaca — Clinical Trial Site

347 Registered trials

153 Currently recruiting

Organisation

University Clinical Hospital Virgen De La Arrixaca

Location

Murcia, Spain

Identifier

ORG-100031138

Address

Carretera Madrid-Cartagena S/N, El Palmar, 30120, Spain

Departments

-
#034005 Oncología
#2030:Hematology
#2042: Unidad de trasplante hematopoyético y terapia celular
#2303:servicio de neurología
#2405: Neurología
#2502, Oncologist
#3273:Urologia
#3416: Cardiología
#40399:Reumatologia
#5412 :neurologia
#9111 Servicio de Hematologia
#93158009: Oncología
#98358009: Oncology
03403: Oncología Médica
1217:Oncología Médica
1304: Neurology
1510: Oncology
2460:Oncologia
2606: Cardiology
2908: Hematology
3102: neurologia
3126: Cardiología
3308: Oncologia
34003: Oncología
3506: Cardiologia
3600; Oncología
4000: Oncología
40350: Unidad Esclerosis Multiple
7014: Oncología
7202: Neurology
Allergology
Cardiología
Cardiology
Cardiology department
Cirugía
Cirugía general
Clinical Research
Cystic Fibrosis Unit, Pediatrics Service
Departamento de Neurología
Digestive surgery
Digestive, Endocrine and Abdominal Organ Transplant Surgery
ES10017: Hematología/Transfusión Med
general surgery and digestive system
Ginecología y Obtetricia
Gynecology and Obstetrics
Haematology
Haematology and Hemotherapy
Haemostasis
Hematología
Hematologist
Hematology
Hematology and Hemotherapy
Hematology Service
Hospital de día de oncohematología infantil Segunda planta del hospital infantil
Hospital Universitario Virgen de la Arrixaca. Servicio de Oncología
Hospital Virgen de la Arrixaca
Infectious Diseases
Intensive Medicine
Internal Medicine
Medical Oncology
Medical Oncology service
N/A
Nephrology
Nephrology Department
Neumology
Neurología
Neurology
Not applicable
Obstetrician and Gynecologist
Oftalmología
Oncohematologia infantil
Oncolgy
Oncología
ONCOLOGÍA MÉDICA
Oncología pediatrica
Oncology
Oncology Department
Oncology Service
Orthopaedic Surgery and Traumatology
Pediatric
Pediatric Hematology and Oncology Unit
Pediatric hematology and oncology
Pediatric oncology
Pediatric Oncology and Hematology
Pediatric oncology department
Pediatric Pneumology and Cystic Fibrosis Unit
Pediatrics
Pediatry
Pulmonary Service
Radiodiagnosis and Breast Cancer
reumatologia
Rheumatology
Servicio de digestivo
servicio cardiologia
Servicio de Cardiologia
Servicio de Hematología
Servicio de medicina interna
Servicio de Neumología
Servicio de neurología
Servicio de Oncología
Servicio de Oncologia Medica
Servicio de Pediatría
Servicio neumologia
Surgery, paediatrics, obstetrics and gynaecology
Thoracic Oncology
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de Esclerosis Múltiple
Unidad de Gestión Clínica de Cirugía Ortopédica y Traumatología
Unidad de Infecciosas
Urology

Clinical trials at this site (347)

Search interface

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
The STARBOARD Study: Phase 3 Study of Encorafenib and Binimetinib Plus Pembrolizumab in BRAF V600E/K Mutation-Positive Metastatic or Unresec… Ended

2024-512038-13-00 Metastatic or unresectable locally advanced BRAF V600E/ 5 2021-09-16
A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended

2023-506368-14-00 Systemic lupus erythematosus (SLE) 5 2021-09-07
A Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel versus Bortezomib, Len… Ended

2023-505850-16-00 Multiple Myeloma 5 2021-08-05
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
PSMAfore: A phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therap… Ended

2023-507772-50-00 PSMA-positive metastatic castration-resistant prostate 5 2021-06-16
A Phase 3 study of Tafasitamab plus Lenalidomide in addition to Rituximab, versus Lenalidomide plus Rituximab in patients With Relapsed/Refr… Ended

2023-504684-16-00 follicular lymphoma (FL) and marginal zone lymphoma (MZ 5 2021-06-05
Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal … Ended

2024-514545-11-00 Knee osteoarthritis 5 2021-05-26
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f… Ended

2023-507961-24-00 High-Risk HER2-Positive Breast Cancer 5 2021-04-19
An Open-label study comparing 177Lu-PSMA-617 plus Standard of Care vs. Standard of Care in the Treatment of mHSPC Ended

2023-507970-42-00 PSMA-positive metastatic hormone-sensitive prostate can 5 2021-03-31
"Study of chemotherapy vs immunotherapy for patients with lung cancer bounded in the thorax and completely resected" Ended

2024-513730-38-00 Resectable Non-small cell lung cancer 5 2021-01-13
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sc… Ended

2023-506515-18-00 Primary Progressive Multiple Sclerosis (PPMS) 5 2020-10-23
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed … Ended

2022-502746-27-00 Endometrial Cancer 5 2020-08-21
A global trial to determine the effectiveness and safety of ION-682884 in patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-… Ended

2024-514434-20-00 Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) 5 2020-06-29
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemop… Ended

2022-502844-11-00 severe to moderately severe hemophilia B (FIX:C ≤ 2%) 5 2020-01-29
Study of Biological Effect in Tumor Samples from Clinical Trial Patients Treated with Ds8201 Ended

2023-508830-33-00 Patients diagnosed with advanced or metastatic cancer t 4 2019-12-13
Phase I-II Study to Assess the Safety, Tolerability and Efficacy of PM01183 and Atezolizumab in Patients with Advanced Small Cell Lung Cance… Ended

2024-517705-93-00 Histologically or cytologically confirmed diagnosis of 9 2019-12-13
Study to evaluate the safety and efficacy of nivolumab combined with ipilimumab as first-line (1L) therapy for participants with advanced HC… Ended

2023-508635-31-00 Hepatocellular Carcinoma 5 2019-12-03
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis Ended

2023-505980-36-00 Primary progressive multiple sclerosis (PPMS) 5 2019-09-19
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive,… Ended

2024-516847-23-00 ER-positive and HER2-negative metastatic or locally adv 4 2019-08-27
Trial of dostarlimab (TSR-042) for patients with high-risk locally advanced cervical cancer after chemo-radiation Ended

2023-510268-11-00 Cervical cancer 4 2019-06-11
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT… Ended

2023-509087-20-00 Metastatic Castration-resistant Prostate Cancer 5 2019-04-16